Progressive Care Reports Positive Q3 EBITDA and Increased Margins

Learn more

About Progressive Care Inc.

At Progressive Care, our mission is to improve every step of the patient journey by adding value to prescribers, caregivers, and patients in a seamless manner. Through the implementation of proven processes, we empower medical practices to achieve the highest standards of personalized care. Learn more about us

Products and Services and their Markets

pharmco-rx-pharmacy

At PharmCo, we take pride in being more than your average pharmacy. We are committed to providing effective, timely, and affordable medications to our patients and the surrounding communities, but our devotion to this mission goes above and beyond.
Learn more about our pharmacy operations

ClearMetrx

ClearMetrX is a full-stack reporting platform that simplifies data analytics for physicians, MSO organizations, 340B entities, and pharmacies.
Learn more about our data management solutions

Releases

Progressive Care Reports Positive Q3 EBITDA and Increased Margins
November 17, 2020
Progressive Care Announces Nine-Month Sales of $30.2 Million, Increase of 31% And Updates September Performance
November 5, 2020
Progressive Care Announces New Partnership with MyApps, Discontinues Plans To Acquire The Company
October 29, 2020

Events

Progressive Care Partners with DeliverSTAT to Support and Expand Rapidly Growing Prescription Delivery Service
September 21, 2020
Progressive Care Issues Corporate Update
September 16, 2020
Progressive Care Announces Second Quarter 2020 Quarterly Call and Business Update on August 17th, 2020
August 14, 2020

Earnings

Progressive Care Reports Positive Q3 EBITDA and Increased Margins
November 17, 2020
Progressive Care Reports Q2 2020 Financials: Sales Up 32%, Over $2M in Cash on Hand
August 16, 2020
Progressive Care Reports Q1 Performance, Net Sales Surpass $9 Million Amid COVID-19 Impact
May 18, 2020
News Releases
Progressive Care Reports July 2020 Performance Data: $3.62M in Gross Sales, and 106% Monthly Growth in 340B Income
MIAMI, FL – August 24, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for July 2020, which continued to demonstrate a trend of robust growth in sales, prescriptions, and 340B income in both sequential monthly and year-over-year terms.
August 25, 2020
Progressive Care Reports Q2 2020 Financials: Sales Up 32%, Over $2M in Cash on Hand
MIAMI, FL – August 17, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for the three months and six months ended June 30, 2020.
August 16, 2020
Progressive Care Announces Departure of CEO and Appoints new interim CEO
MIAMI, FL – August 14, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that Shital Parikh Mars, Chief Executive Officer (“CEO”) and member of the Board of Directors (the “Board”), notified the Board of Directors of her resignation from such positions on August 10, 2020, to pursue other opportunities. The Board accepted the resignation on August 13, 2020
August 14, 2020
Progressive Care Announces Second Quarter 2020 Quarterly Call and Business Update on August 17th, 2020
MIAMI, August 11, 2020 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, August 17th, 2020.
August 14, 2020
Progressive Care Announces Significant Expansion to Establish Full-Service PharmCo Operations and Rapid Testing Services in Orlando Regional Market
‍MIAMI, FL – July 29, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce the expansion of the Company’s PharmCo branded pharmacy operations and presence in the Orlando metropolitan area. The Company is moving out of its current Orlando pharmacy location, which is a 700 square-foot mini-pharmacy operating under the “Five Star” brand designation, to a 3,700 square-foot full-size pharmacy that will open under the PharmCo brand designation.
July 29, 2020
Progressive Care Reports June 2020 Performance Data: Preliminary Q2 Sales Up 33% to $9.32M
MIAMI, FL – July 23, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for June 2020, along with preliminary fiscal Q2 performance data, both of which demonstrate a continued robust trend of growth in sales, prescriptions, 340B income, and COVID-19 testing service revenues.
July 27, 2020
Progressive Care Expands COVID-19 Testing Capabilities to Meet Increased Demand
MIAMI, FL – July 14, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that it has sold through over 90% of its COVID-19 Antibody testing kits. The Company has ordered additional kits and will be expanding testing to meet increasing needs.
July 13, 2020
Progressive Care Launches ClearMetrX Data Analytics Service
MIAMI, FL – June 30, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced the launch of ClearMetrX, the Company’s first wholly-owned data analytics company with services designed to support health care organizations across the country.
June 30, 2020
Progressive Care Announces May 2020 Performance Data: 62% Y/Y Sales Growth on Robust Execution and Expanding Market Share
MIAMI, FL – June 22, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for May 2020, including strong year-over-year growth in the face of continued intense downward pressure from tightening provider prescription demand, with strong execution, patient growth, and expanding Federally Qualified Health Centers (FQHCs) dispensing fees driving robust systemwide performance.
June 23, 2020
Progressive Care Changes Independent Public Accounting Firm to Daszkal Bolton LLP
MIAMI, FL – June 22, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, has engaged Daszkal Bolton LLP as its new independent public accounting firm as it undertakes efforts to transition to reporting under the Exchange Act Reporting requirements.
June 22, 2020
Investors' Presentation

$RXMD is Available on Major Trading Platforms

Progressive Care Inc. is a healthcare management company trading on OTCQB Markets. We encourage visitors to do proper research before investing in OTC Stocks and Penny Stocks. This is not a penny stock recommendation. Progressive Care Inc. main goal is to share relevant and accurate information related to company operations. You can see the full Progressive Care Inc. Audited Annual Report for Fiscal Year Ending in 2019 here.

ameritrade-logo

Ameritrade

Get Started